Two Sigma Advisers
PACB icon

Two Sigma Advisers’s Pacific Biosciences PACB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$31K Sell
25,000
-77,500
-76% -$96.1K ﹤0.01% 2278
2025
Q1
$121K Sell
102,500
-65,400
-39% -$77.2K ﹤0.01% 2218
2024
Q4
$307K Buy
167,900
+27,800
+20% +$50.9K ﹤0.01% 1969
2024
Q3
$238K Buy
140,100
+17,900
+15% +$30.4K ﹤0.01% 2004
2024
Q2
$167K Sell
122,200
-22,200
-15% -$30.4K ﹤0.01% 2249
2024
Q1
$542K Sell
144,400
-7,400
-5% -$27.8K ﹤0.01% 1838
2023
Q4
$1.49M Sell
151,800
-22,600
-13% -$222K ﹤0.01% 1441
2023
Q3
$1.46M Sell
174,400
-20,400
-10% -$170K ﹤0.01% 1361
2023
Q2
$2.59M Buy
194,800
+30,200
+18% +$402K 0.01% 1056
2023
Q1
$1.91M Sell
164,600
-22,400
-12% -$259K ﹤0.01% 1296
2022
Q4
$1.53M Sell
187,000
-796,000
-81% -$6.51M ﹤0.01% 1375
2022
Q3
$5.71M Sell
983,000
-2,597,600
-73% -$15.1M 0.02% 675
2022
Q2
$15.8M Buy
3,580,600
+2,492,300
+229% +$11M 0.04% 380
2022
Q1
$9.9M Buy
1,088,300
+705,900
+185% +$6.42M 0.03% 527
2021
Q4
$7.82M Sell
382,400
-178,400
-32% -$3.65M 0.02% 587
2021
Q3
$14.3M Buy
560,800
+53,500
+11% +$1.37M 0.04% 409
2021
Q2
$17.7M Buy
507,300
+275,500
+119% +$9.63M 0.05% 365
2021
Q1
$7.72M Buy
+231,800
New +$7.72M 0.02% 675
2020
Q1
Sell
-16,600
Closed -$85K 2544
2019
Q4
$85K Sell
16,600
-22,000
-57% -$113K ﹤0.01% 2263
2019
Q3
$199K Sell
38,600
-187,000
-83% -$964K ﹤0.01% 2044
2019
Q2
$1.37M Buy
+225,600
New +$1.37M ﹤0.01% 1377
2018
Q1
Sell
-30,700
Closed -$81K 2389
2017
Q4
$81K Buy
30,700
+12,000
+64% +$31.7K ﹤0.01% 2168
2017
Q3
$98K Buy
+18,700
New +$98K ﹤0.01% 2118
2015
Q1
Sell
-72,600
Closed -$569K 2096
2014
Q4
$569K Buy
+72,600
New +$569K ﹤0.01% 1359